L’étude chimique de l’exsudat glutineux recouvrant les bourgeons et la base des feuilles de Gardenia urvillei Montrouz. et Gardenia oudiepe Vieill., Rubiaceae endémiques de Nouvelle-Calédonie, a conduit à la détermination structurale de douze cycloartanes, neuf seco-cycloartanes, huit dammaranes et sept flavonoïdes. Parmi ces métabolites secondaires, six cycloartanes, quatre seco-cycloartanes et deux dammaranes sont des composés originaux. Les évaluations biologiques sur différentes cibles, notamment la recherche de propriétés anti-angiogéniques par déplacement du VEGF de son récepteur VEGF-R1 ou par inhibition de la polymérisation de la tubuline, ayant montré des résultats encourageants, une chimiothèque d’analogues a été hémisynthétisée. A cette fin, les composés majoritaires en séries cycloartane, dammarane, et flavonoïde, respectivement l’oudiépone A, l’hydroxydammarénone II, la santine, la 5,7-dihydroxy-3,3’,4’,5’,6-pentaméthoxyflavone et le kaempférol ont servi de points de départ à des modifications structurales ayant permis d’accéder à douze cycloartanes, deux seco-cycloartanes, trois dammaranes, un seco-dammarane et huit flavonoïdes supplémentaires. Un début de relation structure-activité a ainsi pu être décrit dans les domaines mentionnés précédemment. / Phytochemical studies of glutinous exudate covering the buds et the leaf base of Gardenia urvillei Montrouz. et Gardenia oudiepe Vieill., Rubiaceaeous species endemic to New Caledonia, have led to the identification of twelve cycloartanes, nine seco-cycloartanes, eight dammaranes et seven flavonoids. Among these secondary metabolites, six cycloartanes, four seco-cycloartanes et two dammaranes are original natural products. Biological evaluations, such as search for anti-angiogenic properties or inhibition of tubulin polymerization, have shown promising results. In order to establish the structure-activity relationships for these activities, twenty-six analogs were semisynthesized from the major isolated compounds, oudiépone A, hydroxydammarénone II, santin, 5,7-dihydroxy-3,3’,4’,5’,6-pentamethoxyflavone et kaempferol.

Magister Pharmaceuticae - MPharm / Sutherlandia frutescens (tribe Galegeae, Fabaceae), is a popular medicinal plant traditionally used in South Africa. In 2000, a company called Phyto Nova (Pty) Ltd. initiated large-scale cultivation and contract manufacturing of tablets, made from the powdered herb (i.e. thin stems and leaves). Most of these commercial Sutherlandia solid dosage forms are made from the dried leaf powder but recently a new product, viz. Promune™ capsules, made from a freeze-dried aqueous extract, came on the market and was claimed to be “better” as it mimics the traditional tea. However, the pharmaceutical quality and stability of these preparations have not yet been investigated. The objectives of this study were firstly, to develop a validated stability-indicating HPLC assay for sutherlandioside B (SU-B); secondly, to compare the SU-B levels in the two commercially available Sutherlandia products viz, the Phyto Nova Sutherlandia SU1™ tablet and the Promune™ capsule, and, thirdly, to determine the effect of elevated temperature and humidity as well as acid hydrolysis on the SU-B levels in these two products. / South Africa

<p>Sutherlandia frutescens (tribe Galegeae, Fabaceae), is a popular medicinal plant traditionally used in South Africa. In 2000, a company called Phyto Nova (Pty) Ltd. initiated large-scale cultivation and contract manufacturing of tablets, made from the powdered herb (i.e. thin stems and leaves). Most of these commercial Sutherlandia solid dosage forms are made from the dried leaf powder but recently a new product, viz. Promune&trade / capsules, made from a freeze-dried aqueous extract, came on the market and was claimed to be &ldquo / better&rdquo / as it mimics the traditional tea. However, the pharmaceutical quality and stability of these preparations have not yet been investigated. The objectives of this study were firstly, to develop a validated stability-indicating HPLC assay for sutherlandioside B (SU-B) / secondly, to compare the SU-B levels in the two commercially available Sutherlandia products viz, the Phyto Nova Sutherlandia SU1&trade / tablet and the Promune&trade / capsule, and, thirdly, to determine the effect of elevated temperature and humidity as well as acid hydrolysis on the SU-B levels in these two products.</p>

<p>Sutherlandia frutescens (tribe Galegeae, Fabaceae), is a popular medicinal plant traditionally used in South Africa. In 2000, a company called Phyto Nova (Pty) Ltd. initiated large-scale cultivation and contract manufacturing of tablets, made from the powdered herb (i.e. thin stems and leaves). Most of these commercial Sutherlandia solid dosage forms are made from the dried leaf powder but recently a new product, viz. Promune&trade / capsules, made from a freeze-dried aqueous extract, came on the market and was claimed to be &ldquo / better&rdquo / as it mimics the traditional tea. However, the pharmaceutical quality and stability of these preparations have not yet been investigated. The objectives of this study were firstly, to develop a validated stability-indicating HPLC assay for sutherlandioside B (SU-B) / secondly, to compare the SU-B levels in the two commercially available Sutherlandia products viz, the Phyto Nova Sutherlandia SU1&trade / tablet and the Promune&trade / capsule, and, thirdly, to determine the effect of elevated temperature and humidity as well as acid hydrolysis on the SU-B levels in these two products.</p>

Magister Pharmaceuticae - MPharm